Noam Maoz, PhD

Noam Maoz, PhD, is the co-founder and CTO of Centarix, a Jerusalem-based biotechnology company focused on developing innovative longevity treatments to combat age-related decline. Driven by his
passion for advancing the field, Noam leads a multidisciplinary team at Centarix that is developing aunique in-house panel of biological-age diagnostics, which is currently undergoing clinical trials.
Additionally, he is working on a novel cellular epigenetic rejuvenation approach and exploring cutting-edge delivery methods.
Noam earned his PhD in molecular biology from Bar-Ilan University, where he studied genetic manipulations targeting aging in eukaryotes. He then completed his postdoctoral training at Hebrew
University-Hadassah Medical School, focusing on cellular reprogramming, epigenetic mechanisms of aging, and initiating a new approach for epigenetic rejuvenation.
Country: Israel
Visit Website